Im. Gallagher et al., Long-term effects of pergolide and (-)-deprenyl on H-3-mazindol and H-3-spiperone binding in rat brains, NEUROBIOL A, 20(6), 1999, pp. 709-713
The effects of long-term administration of the putative neuroprotective age
nts pergolide and (-)-deprenyl was assessed by studying H-3-mazindol and H-
3-spiperone binding at 12 and 20 months in the major dopamine brain regions
. Male Wistar rats were treated from 3 to 20 months, together with their re
spective untreated and saline injected control groups. The main findings we
re: 1) there was a decrease in both H-3-mazindol and H-3-spiperone binding
with age between 12 and 20 months; 2) there were no differences at 20 month
s between the pergolide or the (-)-deprenyl treated groups and their contro
ls, thus providing no evidence for long-term neuroprotection; and 3) there
was a marked decrease in H-3-mazindol binding in the injected controls comp
ared with the untreated controls at both 12 and 20 months. This raises the
possibility that mild chronic stress may accelerate the aging of the dopami
ne system. (C) 2000 Elsevier Science Inc. All rights reserved.